301.66
-6.12(-1.99%)
Currency In USD
Previous Close | 307.78 |
Open | 304.88 |
Day High | 307.03 |
Day Low | 298.73 |
52-Week High | 377.46 |
52-Week Low | 189 |
Volume | 236,903 |
Average Volume | 380,722 |
Market Cap | 6.66B |
PE | -13.77 |
EPS | -21.9 |
Moving Average 50 Days | 330.5 |
Moving Average 200 Days | 289.57 |
Change | -6.12 |
If you invested $1000 in Madrigal Pharmaceuticals, Inc. (MDGL) 10 years ago, it would be worth $2,982.3 as of April 19, 2025 at a share price of $301.66. Whereas If you bought $1000 worth of Madrigal Pharmaceuticals, Inc. (MDGL) shares 5 years ago, it would be worth $3,432.24 as of April 19, 2025 at a share price of $301.66.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Madrigal Pharmaceuticals to Release First-Quarter 2025 Financial Results and Host Webcast on May 1, 2025
GlobeNewswire Inc.
Yesterday at 12:00 PM GMT
CONSHOHOCKEN, Pa., April 18, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), announced today t
Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. to Become Senior Scientific and Medical Advisor; David Soergel, M.D., Appointed Chief Medical Officer
GlobeNewswire Inc.
Apr 16, 2025 11:00 AM GMT
Dr. Taub’s pioneering research in academia and industry led to the first FDA-approved therapy for patients with MASHCONSHOHOCKEN, Pa., April 16, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company foc
Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors
GlobeNewswire Inc.
Mar 11, 2025 12:00 PM GMT
Fred Craves, Ph.D. to retire from Madrigal’s Board of Directors in July 2025 CONSHOHOCKEN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics fo
Data not available